Pharvaris (PHVS) Cash & Equivalents (QoQ) (2021 - 2026)
Pharvaris (PHVS) Cash & Equivalents (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - |
| 10 | Pharvaris | 2.23 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.84% |
| Dec 31, 2025 | -11.80% |
| Sep 30, 2025 | 70.40% |
| Jun 30, 2025 | -9.19% |
| Mar 31, 2025 | -17.07% |
| Dec 31, 2024 | -10.50% |
| Sep 30, 2024 | -9.41% |
| Jun 30, 2024 | -7.54% |
| Mar 31, 2024 | -4.94% |
| Dec 31, 2023 | 144.18% |
| Sep 30, 2023 | -11.65% |
| Jun 30, 2023 | 34.48% |
| Mar 31, 2023 | -12.12% |
| Dec 31, 2022 | -17.18% |
| Sep 30, 2022 | -7.22% |
| Jun 30, 2022 | -1.70% |
| Mar 31, 2022 | -8.72% |
| Dec 31, 2021 | -7.10% |
| Sep 30, 2021 | -4.57% |
| Jun 30, 2021 | -6.03% |